{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "A recent report that one of the most widely prescribed antidepressants, Paxil, might be linked to an increased risk of suicidal thinking in teenagers and children has sent a wave of anxiety through doctors and depressed patients alike. After all, millions of depressed patients have been treated with Paxil as well as Prozac, Zoloft and Celexa, which are all selective serotonin reuptake inhibitors -- that is, they regulate the activity of the neurotransmitter serotonin in the brain, which improves mood. And while there were several reports in the early 1990's suggesting a possible link between this class of drugs and an increased risk of suicidal behavior, the Food and Drug Administration cleared S.S.R.I.'s of any association with suicide in 1991.", "headline": {"main": "What You Do Know Can't Hurt You"}, "abstract": "Op-Ed article by Dr Richard A Friedman, psychiatrist, on recent report that widely prescribed antidepressant Paxil and others of its ilk might be linked to increased risk of suicidal thinking in teenagers and children; says report comes from unpublished study sponsored by Paxil's manufacturer, GlaxoSmithKline; says even if small subset of patients do become more suicidal after taking Paxil, risk of treatment is dwarfed by risk of untreated depression, since 5 percent to 10 percent of patients with major depression eventually commit suicide; says, however, that Food and Drug Administration should require drug manufacturers to publish results of all their studies (M)", "print_page": "17", "word_count": 891, "_id": "4fd296ab8eb7c8105d872cd3", "snippet": "A recent report that one of the most widely prescribed antidepressants, Paxil, might be linked to an increased risk of suicidal thinking in teenagers and children has sent a wave of anxiety through doctors and depressed patients alike.     After all,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/12/opinion/what-you-do-know-can-t-hurt-you.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "GLAXOSMITHKLINE PLC"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PAXIL (DRUG)"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"firstname": "Richard", "middlename": "A.", "lastname": "Friedman", "rank": 1, "role": "reported", "organization": ""}], "original": "By Richard A. Friedman"}, "document_type": "article", "pub_date": "2003-08-12T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Terry Heaton will not find out for at least another year whether the pills she tried for hot flashes were just blanks or really black cohosh, the much ballyhooed Native American remedy for women's ailments. As a participant in a federally financed study at Columbia University who dutifully recorded the frequency and severity of her hot flashes over 12 months, Ms. Heaton, a 56-year-old retired airline employee, could see that her menopausal symptoms were diminishing. She was definitely sleeping better.", "headline": {"main": "Herbs for Hot Flashes: New Attention, Mixed Results"}, "abstract": "Various studies exploring use of herbs, dietary supplements and diet modifications yield mixed results in helping with symptoms of menopause; data confuse already disillusioned female population, after string of negative studies on widely used hormone replacement therapy; black cohosh, native American remedy, appears frontrunner among herbal remedies with several studies underway and some six-month trials completed; Amy Allina, National Women's Health Network in Washington's policy and program director, warns women not to assume because product is natural that it is safe; other studies are being done on effects of red clover, soy, flax seed, macrobiotic diets and alternative therapies such as acupuncture and relaxation techniques, some of which show promise; primary symptom of menopause, hot flashes, remains mysterious to doctors and, surprisingly, placebos are effective in relieving them in 30% of trial cases; photo (L)", "print_page": "5", "word_count": 1432, "_id": "4fd244ea8eb7c8105d7df8b8", "snippet": "Terry Heaton will not find out for at least another year whether the pills she tried for hot flashes were just blanks or really black cohosh, the much ballyhooed Native American remedy for women's ailments.    As a participant in a federally financed...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/12/health/herbs-for-hot-flashes-new-attention-mixed-results.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ALLINA, AMY"}, {"name": "organizations", "value": "WOMEN'S HEALTH NETWORK"}, {"name": "subject", "value": "DIET AND NUTRITION"}, {"name": "subject", "value": "ACUPUNCTURE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CLOVER (PLANT)"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "MENOPAUSE"}, {"name": "subject", "value": "FLAX"}, {"name": "subject", "value": "DIETARY SUPPLEMENTS AND HERBAL REMEDIES"}, {"name": "subject", "value": "INDIANS, AMERICAN"}, {"name": "subject", "value": "PLACEBOS"}, {"name": "subject", "value": "BLACK COHOSH (HERB)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "SOYBEANS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Leslie", "lastname": "BERGER"}], "original": "By LESLIE BERGER"}, "document_type": "article", "pub_date": "2003-08-12T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "After four years of chronic recession, few Argentine companies can boast a clean bill of financial health. But for the generic drug maker Fada Pharma, the country's economic crisis has been nothing short of a tonic. Thanks to a new generics law, hastily passed by decree in 2002 just as the economy hit rock bottom, Fada rode out the crisis and is now growing fast, selling an expanding range of no-brand drugs to pharmacies and drugstores.", "headline": {"main": "Generics Shake Up a Drug Industry"}, "abstract": "New law, born of patent legislation that came into force in 2000, shook up Argentina's drug industry; law not only changed consumer buying patterns, but also forced bigger drug companies to lower prices, redraw their marketing strategies and even look overseas to make up for shrinking margins at home; drugs market, worth nearly $6 billion in mid-1990's, shrank to $1.2 billion in 2002; Fada Pharma general manager Eduardo Epstein says its work force, reduced to 200 in 2002 from 270 employees before crisis, is up to 300; sales in 2003 are expected to top 65 million pesos, up 44 percent from 25.5 million pesos in 2000, and are recovering even in dollar terms; photos (M)", "print_page": "1", "word_count": 1064, "_id": "4fd291bf8eb7c8105d86aa96", "snippet": "After four years of chronic recession, few Argentine companies can boast a clean bill of financial health. But for the generic drug maker Fada Pharma, the country's economic crisis has been nothing short of a tonic.    Thanks to a new generics law,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/12/business/generics-shake-up-a-drug-industry.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "EPSTEIN, EDUARDO"}, {"name": "glocations", "value": "ARGENTINA"}, {"name": "organizations", "value": "FADA PHARMA"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "HIRING AND PROMOTION"}, {"name": "subject", "value": "INDUSTRY PROFILES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tony", "lastname": "SMITH"}], "original": "By TONY SMITH"}, "document_type": "article", "pub_date": "2003-08-12T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Bush administration officials say they expect to cut Medicare payments to doctors by 4.2 percent next year unless Congress passes legislation to reduce or eliminate the cut. In a proposed rule to be published on Friday, the administration says the cut is required by the existing Medicare law. Many doctors and some members of Congress disagree.", "headline": {"main": "Medicare Fees For Physicians In Line for Cuts"}, "abstract": "Bush administration officials say they expect to cut Medicare payments to doctors by 4.2 percent next year unless Congress passes legislation to reduce or eliminate cut; say cut is required by existing Medicare law, but many doctors and some members of Congress disagree; Medicare officials say Congress could avert cut as part of legislation to add drug benefits to Medicare; there is no guarantee Congress will finish work on bill before Jan 1, when cut is to take effect; administration officials say cut in Medicare payments to doctors would not harm beneficiaries or hurt their ability to obtain care; doctors say new cut, after 5.4 percent cut last year, would give them fresh incentive to limit number of elderly patients; doctors repeatedly express concern that Medicare payments are not keeping up with their costs (M)", "print_page": "1", "word_count": 801, "_id": "4fd244ea8eb7c8105d7df8be", "snippet": "Bush administration officials say they expect to cut Medicare payments to doctors by 4.2 percent next year unless Congress passes legislation to reduce or eliminate the cut.    In a proposed rule to be published on Friday, the administration says the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/12/us/medicare-fees-for-physicians-in-line-for-cuts.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-08-12T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Alex is still a 34-year-old recovering addict, trying to measure what he lost to heroin. He is still building a new life in Manhattan, repairing frayed relationships and an interrupted career in the entertainment industry. He is still reliant on a substitute drug to get him through the day. But three months ago, he switched substitutes, and his life changed for the better. Alex -- he told his story on the condition that his full name not be used -- stopped taking methadone, since the 1960's the standard treatment for people trying to quit heroin. Instead, he takes buprenorphine, a drug newly approved by federal regulators to treat addiction to heroin and other opiates, including prescription drugs.", "headline": {"main": "New Drug Promises Shift in Treatment For Heroin Addicts"}, "abstract": "Buprenorphine, drug newly approved by federal regulators to treat addiction to heroin and other opiates, is thought to have several advantages over methadone, standard treatment since 1960's; buprenorphine has lower risk of overdose than methadone and will not give addict more than mild high no matter how large the dose; it cannot be combined with opiates or other narcotics to get higher still; users suffer fewer unpleasant side effects, and milder withdrawal symptoms when they stop taking it; most important may be that patient can get supply, not merely a dose, with visit to doctor and pharmacy; experts say advent of buprenorphine could triple number of people in serious treatment for heroin addiction; some experts caution that much remains to be learned about buprenorphine; recall that methadone, too, was once seen as wonder drug; photo (M)", "print_page": "1", "word_count": 1491, "_id": "4fd22c568eb7c8105d7b844f", "snippet": "Alex is still a 34-year-old recovering addict, trying to measure what he lost to heroin. He is still building a new life in Manhattan, repairing frayed relationships and an interrupted career in the entertainment industry. He is still reliant on a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/11/nyregion/new-drug-promises-shift-in-treatment-for-heroin-addicts.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PEREZ-PENA, RICHARD"}, {"name": "subject", "value": "HEROIN"}, {"name": "subject", "value": "BUPRENORPHINE (DRUG)"}, {"name": "subject", "value": "METHADONE"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Richard", "lastname": "P\u00c9REZ-PE\u00d1A"}], "original": "By RICHARD P\u00c9REZ-PE\u00d1A"}, "document_type": "article", "pub_date": "2003-08-11T00:00:00Z", "section_name": "Front Page; Health; New York and Region"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: Re ''Debate Resumes on the Safety of Depression's Wonder Drugs'' (front page, Aug. 7): A number of years ago I experienced a minor depressive episode. I was put on a serotonin inhibitor called Celexa. I had never had suicidal thoughts before the drug therapy, nor did I begin to have them during the course of treatment. But during the first month, I experienced extreme, almost manic tendencies. My mind raced, I was restless, I couldn't sleep. Eventually that restlessness subsided.", "headline": {"main": "The Debate Over Antidepressants"}, "abstract": "Steve Matics letter relates his experience with serotonin inhibitor Celexa (Aug 7 article)", "print_page": "14", "word_count": 191, "_id": "4fd2332f8eb7c8105d7c3790", "snippet": "To the Editor:    Re ''Debate Resumes on the Safety of Depression's Wonder Drugs'' (front page, Aug. 7):    A number of years ago I experienced a minor depressive episode. I was put on a serotonin inhibitor called Celexa. I had never had suicidal...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/11/opinion/l-the-debate-over-antidepressants-863084.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MATICS, STEVE"}, {"name": "subject", "value": "CELEXA (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}], "byline": null, "document_type": "article", "pub_date": "2003-08-11T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Travel Desk", "lead_paragraph": "ANYONE who has traveled in the summer most likely has a tale of a trip marred by visitors who have a tendency to appear just as a picnic dinner is spread out or alfresco evening drinks are served. Usually arriving stealthily by air, these stinging, biting uninvited guests tend to have a favorite host among the crowd. As one of their regular picks, I can catalog an impressive number of trips according to which bug tormented me and how many bites I endured. These days, of course, some insects are more than an annoyance, with potentially deadly mosquito-borne illnesses like the West Nile virus and Eastern equine encephalitis a growing concern in the United States, and malaria and yellow fever a continuing problem around the world. Mosquitoes are not the only insects that can ruin a backyard picnic or excursion halfway around the world: ticks, black flies and fleas are among the bugs I have fended off in my travels near and far from home.", "headline": {"main": "Preventing Bites (And Worse)", "kicker": "PRACTICAL TRAVELER"}, "abstract": "Susan Stellin Practical Traveler column offers advice on preventing insect bites and diseases carried by insects while traveling; drawing (M)", "print_page": "4", "word_count": 1185, "_id": "4fd22f118eb7c8105d7bce4b", "snippet": "ANYONE who has traveled in the summer most likely has a tale of a trip marred by visitors who have a tendency to appear just as a picnic dinner is spread out or alfresco evening drinks are served. Usually arriving stealthily by air, these stinging,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/10/travel/practical-traveler-preventing-bites-and-worse.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "INSECTS"}, {"name": "subject", "value": "TRAVEL AND VACATIONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Susan", "lastname": "STELLIN"}], "original": "By SUSAN STELLIN"}, "document_type": "article", "pub_date": "2003-08-10T00:00:00Z", "section_name": "Travel"}], "meta": {"hits": 7, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}